“I have a patient with esophageal cancer being treated in a clinical trial.  ITA connected with me at the insurer’s request, because they had a question about the treatment; they were most likely going to deny payment.  I was surprised to be talking with an oncologist — a colleague with excellent clinical understanding.  Based on our discussion, the patient’s treatment was approved.” -- Dr. K.D., New Hampshire